CA-GVK-BIO
Aragen Bioscience, Inc, a subsidiary unit of GVK BIO and one of the leading pre-clinical CRO specializing in monoclonal antibody and other large-molecule product development and Serum Institute of India Pvt. Ltd. (Serum), the world's largest vaccine manufacturer, are pleased to announce a collaboration for the development of multiple stable cell lines to support Serum’s HIV program. This partnership between Serum and Aragen unites two organizations that are committed to ‘Accelerating Life Sciences R&D’ with the goal of developing affordable monoclonal antibodies that improve the quality of human life.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200108005030/en/
Aragen will leverage its expertise with their RapTr™ platform utilizing proprietary vectors and CHO DG44 host cells to develop the cell lines. Combined with the analytics platform, Aragen is set to provide Serum with high expressing cell lines enabling Serum to quickly move their program forward into Manufacturing. With a proven track record of more than 50 years in developing affordable medicines, Serum will focus its efforts on advancing these novel molecules into impactful vaccines or therapies that treat and prevent diseases world-wide.
“We are delighted to partner with the global leader in Vaccines,” said Manni Kantipudi, Chairman, Aragen, & Chief Executive Officer, GVK BIO . “The Aragen team is recognized globally for its ability to clone and express challenging proteins. Through this collaboration with Serum, we expect to build on this expertise to develop and deliver affordable biologicals.”
“SIIPL is very pleased to join hands with Aragen. SIIPL is already in collaboration with IAVI and Scripps Research for discovery of novel monoclonal antibodies against HIV. With our manufacturing capabilities and this collaboration with Aragen to develop stable cell lines, SIIPL will be able to provide cost effective monoclonal antibodies against HIV for the developing and developed world,” stated Mr. Adar Poonawalla, CEO, SIIPL .
About GVK BIO
GVK BIO, a leading Contract Research & Development Organization servicing the global Life-sciences industry, is headquartered in Hyderabad, India with operations in five sites including Aragen Bioscience, Inc. in California, USA. Established in 2001, GVK BIO has over 19 years of experience across the Research and Development value chain with a focus on speed and quality while ensuring safety and compliance. GVK BIO’s team of over 2500 highly qualified scientists, backed by a no-conflict business model, well-defined and scalable processes, modern facilities, and a strong customer-centric partnering approach, focus on bringing its customers’ products to market. www.gvkbio.com
About Serum
Serum Institute of India Pvt. Ltd. was founded in 1966 by Dr. Cyrus Poonawalla with a mission of manufacturing life-saving immuno-biologics. Serum is the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.3 billion doses). It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by Serum Institute. Vaccines manufactured by Serum are accredited by the World Health Organization, Geneva and are being used in approximately 170 countries across the globe.
Serum is ranked as India's No. 1 biotechnology company, manufacturing highly specialized lifesaving biologics like vaccines using cutting edge genetic and cell-based technologies, antisera and other medical specialties.
The philanthropic philosophy of Serum continues with its work on newer vaccines and biologicals.
Learn more about Serum Institute of India at https://www.seruminstitute.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20200108005030/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
“B-Logic” Debuts at Kingpins Amsterdam13.10.2025 15:00:00 CEST | Press release
Five Companies Unite to Reimagine Denim and Showcase Sustainable Solutions In a bold move toward redefining denim, five trailblazing companies — Circulose, iTextiles®, Labor Made Inc., Neela, and The LYCRA Company — are joining forces to launch B-Logic: The Logical Future of Denim at Kingpins Amsterdam, October 15 – 16. Sugar Factory visitors can explore the sustainable collection of denim and wovens on the mezzanine level. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251013240355/en/ In a bold move toward redefining denim, five trailblazing companies — Circulose, iTextiles®, Labor Made Inc., Neela, and The LYCRA Company — are joining forces to launch B-Logic: The Logical Future of Denim at Kingpins Amsterdam, October 15 – 16, 2025. Short for Being Logical, B-Logic is a visionary collaboration that takes a thoughtful and rational approach to developing the next generation of modern, sustainable denim. Every decision, from
Lattice Launches Industry-First PQC-Ready FPGA Family: MachXO5-NX TDQ13.10.2025 15:00:00 CEST | Press release
‒ Sets new standard for secure control FPGAs with full CNSA 2.0-compliant post-quantum cryptography, crypto-agility, and hardware root of trust for next-generation infrastructure ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today introduced the Lattice MachXO5™-NX TDQ family, the industry’s first secure control FPGAs with full Commercial National Security Algorithm (CNSA) 2.0-compliant post-quantum cryptography (PQC) support. Built on the award-winning Lattice Nexus™ platform, MachXO5-NX TDQ FPGAs deliver unmatched security, reliability, and flexibility for Computing, Communications, Industrial, and Automotive applications as the threat of quantum-enabled cyberattacks rises. “Quantum computing advances increase the urgency to adopt quantum-resistant security across every industry,” said Esam Elashmawi, Chief Strategy and Marketing officer, Lattice Semiconductor. “With MachXO5-NX TDQ, Lattice is first to market with a secure control FPGA family that not onl
Boomi Recognized as a Leader in the 2025 Gartner® Magic Quadrant™ for API Management13.10.2025 15:00:00 CEST | Press release
Boomi’s recognition as a Leader in API management reflects its execution and vision Boomi™, the leader in AI-driven automation, today announced it has been recognized as a Leader in the 2025 Gartner® Magic Quadrant™ for API Management. This recognition reflects Boomi’s strength in both ability to execute and completeness of vision, which in Boomi’s view, reaffirms the company’s focus on powering API innovation at the core of agentic transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251013735773/en/ Boomi Recognized as a Leader in the 2025 Gartner® Magic Quadrant™ for API Management “As organizations race to unlock the full value of agentic AI, APIs have never been more critical,” said Steve Lucas, Chairman and CEO at Boomi. “That’s why it’s so meaningful that Boomi is the only vendor recognized as a Leader in both the 2025 Gartner® Magic Quadrant™ for API Management and the 2025 Gartner® Magic Quadrant™ for Inte
Sutherland Unveils Insurance AI Hub to Break Industry’s ‘Pilot Trap’13.10.2025 14:41:00 CEST | Press release
Purpose-built Agentic AI ecosystem with specialized agents already delivering measurable ROI in underwriting, claims, policyholder servicing, and more Sutherland, a global leader in business and digital transformation, today announced the launch of its Insurance AI Hub, an agentic AI ecosystem engineered to solve the scale, compliance, and ROI challenges insurers face in operationalizing AI. Unlike generalized AI platforms retrofitted for insurance or siloed tools that rarely make it beyond the demo stage, Sutherland’s solution is trained on real insurance workflows, tuned for regulatory demands, and already being deployed by enterprises today. Now with a comprehensive suite of specialized AI agents engineered for Life & Annuity, Group Benefits, Property & Casualty, and Specialty lines, the Insurance AI Hub lets insurers break free from proof-of-concept paralysis and finally scale AI with confidence. Sutherland’s AI offerings come with important enterprise guardrails already in place,
FoodChain ID Certifies Mulino Bianco’s Buongrano to Regenerative Agriculture (RGN) Standard13.10.2025 13:00:00 CEST | Press release
Italy’s leading baked-goods company, a Barilla Group brand, introduces the country’s first cookie certified with 100% regenerative soft wheat flour. FoodChain ID today announced that Mulino Bianco’s Buongrano has been certified to the FoodChain ID Regenerative Agriculture (RGN) Certification, marking Italy’s first bakery brand to introduce a cookie certified with 100% regenerative soft wheat flour.1 The certification provides independent verification of regenerative outcomes and will be communicated on-pack via the FoodChain ID RGN mark, helping consumers identify products sourced from farms advancing soil health, biodiversity and climate resilience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251013488950/en/ FoodChain ID today announced that Mulino Bianco’s Buongrano has been certified to the FoodChain ID Regenerative Agriculture (RGN) Certification, marking Italy’s first bakery brand to introduce a cookie certified wit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom